Results 21 to 30 of about 94,068 (259)

Ki-67 Antigen in Lung Neuroendocrine Tumors: Unraveling a Role in Clinical Practice [PDF]

open access: yesJournal of Thoracic Oncology, 2014
Classification of lung neuroendocrine (NE) tumors is a step-wise process with four tumor categories being identified by morphology, namely typical carcinoid (TC), atypical carcinoid, large-cell NE carcinoma, and small-cell lung carcinoma (SCLC). Ki-67 antigen or protein (henceforth simply Ki-67) has been largely studied in these tumors, but the ...
Pelosi, G   +3 more
openaire   +2 more sources

IMMUNOHISTOCHEMICAL STUDY OF Ki-67 ANTIGEN EXPRESSION IN DIAGNOSIS OF PSORIASIS

open access: yesPARIPEX INDIAN JOURNAL OF RESEARCH, 2021
Background: Psoriasis is a common, chronic inflammatory skin disease characterized by scaly white papules and pinpoint bleeding on scratching. Presence of keratinocyte hyperproliferation and abnormal differentiation in the epidermis are some significant features.
Depika Sanasam   +3 more
openaire   +1 more source

Influence of Ki-67 and proliferating cell nuclear antigen expression on the biological behavior of ameloblastomas

open access: yesDentistry and Medical Research, 2018
Background: Ameloblastomas, the second-most common odontogenic tumors, are locally aggressive benign lesions that derive from cellular components of the enamel organ.
Alberto Rodriguez-Archilla   +1 more
doaj   +1 more source

Prognostic Value of Ki 67 Proliferation Antigen in Canine Malignant Mammary Gland Tumours

open access: yesBrazilian Journal of Veterinary Pathology, 2011
Canine malignant mammary gland tumours were surgically resected from 78 dogs to determine the prognostic value of Ki 67 Proliferation antigen. After post surgical follow up for minimum of 1 year, 48 dogs were still alive, while 21 dogs had died as a ...
Jayachandra C. Kadthur   +4 more
doaj   +1 more source

Ki-67 expression in squamous intraepithelial lesions of the uterine cervix [PDF]

open access: yesArchive of Oncology, 2006
BACKGROUND: Uncontrolled cell proliferation and malignant transformation are the basic elements in the development of malignant disease including cervical cancer and its precursors.
Panjković Milana   +1 more
doaj   +1 more source

Ki-67 expression as an indicator of invasiveness in patients with breast cancer

open access: yesMedical Journal of Babylon, 2018
Background: Tumor markers have a key role in guiding breast cancer management protocols and predicting prognosis. Objective: The aim of the study is to explore the role of Ki-67 expression in breast cancer and correlate it to well-known indicators of ...
Ahmed Salah Mahdi   +2 more
doaj   +1 more source

Radiomic prediction models for the level of Ki-67 and p53 in glioma

open access: yesJournal of International Medical Research, 2020
Objective To identify glioma radiomic features associated with proliferation-related Ki-67 antigen and cellular tumour antigen p53 levels, common immunohistochemical markers for differentiating benign from malignant tumours, and to generate radiomic ...
Xiaojun Sun   +5 more
doaj   +1 more source

Proliferative activity in ovarian endometrrioma

open access: yesJournal of Education, Health and Sport, 2018
Endometriosis shows features similar to neoplasia, which recently increased interest in the monoclonal antigen Ki-67. The aim of the study was to study the expression of Ki-67 in the operated ovarian endometriomas in women of reproductive age.
V. G. Dubinina   +2 more
doaj   +3 more sources

Expression of Ki-67 in Oral Lichen Planus: A Systematic Review and Meta-Analysis [PDF]

open access: yesJournal of Dentistry
Statement of the Problem: One of the main signs of cancer development is increasing of cell proliferation activity. Expression of the Ki-67 as a cell proliferation marker is extensively utilized in pathology studies as an indicator of proliferation in ...
Ayla Bahramian   +2 more
doaj   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Home - About - Disclaimer - Privacy